BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Corus Pharma, Inc. 

A subsidiary of Gilead Sciences
2025 First Avenue, Suite 800
Seattle  Washington  98121  U.S.A.
Phone: 206-728-5090 Fax:


SEARCH JOBS
Corus Pharma is a biopharmaceutical company committed to developing and commercializing products for severe respiratory and infectious diseases that can help provide improved health and superior quality of life. More information about Corus Pharma may be found at www.coruspharma.com.

We are located in the heart of downtown Seattle, just one block from the historic Pike Place Market. We offer competitive compensation and health benefits, casual work environment, 401(k), stock options, parking and health club subsidy.

Last Updated: 12-15-04


 Key Statistics


Email: resumes@coruspharma.com
Ownership: Private

Web Site: Corus Pharma, Inc.
Employees:
Symbol: 
 




Segment
Pharmaceuticals





 Company News
Gilead Sciences (Foster City, CA) (GILD) Completes Acquisition Of Corus Pharma, Inc. 8/14/2006 10:56:31 AM    More...
Gilead Sciences (Foster City, CA) (GILD) Exercises Option To Acquire Corus Pharma, Inc. For $365 Million 8/3/2006 12:56:44 PM    More...
The Day In Review: Gilead Sciences (Foster City, CA) (GILD) Pays $365 Million For Corus Pharma, Inc. 7/20/2006 4:52:19 PM    More...
Gilead Sciences (Foster City, CA) (GILD) Agrees To Exercise Its Option To Acquire Corus Pharma, Inc. For $365 Million 7/20/2006 10:37:03 AM    More...
Gilead Sciences (Foster City, CA) (GILD) Invests $25 Million In Corus Pharma, Inc. 4/12/2006 4:44:14 PM    More...
Corus Pharma, Inc. Withdraws IPO Plan 2/17/2006 1:31:35 PM    More...
PARI Aerosol Research Institute's Formulation Work And eFlow Featured In Corus Pharma, Inc.'s Positive Phase II Trial Results 10/19/2005 5:11:53 PM    More...
Corus Pharma, Inc. Announces Positive Phase II Results For Cystic Fibrosis Drug 10/19/2005 5:11:51 PM    More...
Corus Pharma, Inc. Hires Chief Commercial Officer 10/19/2005 5:11:49 PM    More...
Corus Pharma, Inc. Finalizes Series C Financing Round With An Additional $5 Million 10/19/2005 5:11:24 PM    More...
12

//-->